P060: Surveillance and control of community-associated methicillin-resistant Staphylococcus aureus in Geneva, Switzerland, 2002 – 2012
Philippe Sudre, Patrice François(University Hospital of Geneva), Elodie von Dach(University Hospital of Geneva), R Auckenthaler, Nadia Liassine, Gesuèle Renzi, Angela Huttner(University Hospital of Geneva), Marie-Christine Descombes(Union Bank of Switzerland), Stéphan Harbarth(World Health Organization)
Cited by 1
Related Papers
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
|Intensive Care Medicine|2023|293
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
|The Lancet Infectious Diseases|2015|278
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage
|Clinical Microbiology and Infection|2019|263
Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials
|Journal of Antimicrobial Chemotherapy|2015|262